JNCI Cancer Spectrum
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.8 | Q2 | 72.7% | 1.720 | Q1 | 93.7% |
| 2024 | 4.1 | Q2 | 72.4% | 2.236 | Q1 | 96.2% |
| 2023 | 3.4 | Q2 | 62.7% | 2.101 | Q1 | 95.9% |
| 2022 | 4.4 | 65.2% | 2.377 | Q1 | 96.8% | |
| 2021 | — | 25.2% | 1.773 | Q1 | 94.9% | |
| 2020 | — | — | 1.345 | Q2 | 90.9% | |
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2515-5091
country
GBcoverage
2017-2026